New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta (duloxetine HCl) once daily experienced significant pain reduction. Patients taking duloxetine reported significant pain improvement compared to placebo within the first week of treatment that lasted throughout the 13-week trial. Results from the study of 231 [...]
Patients who suffer the chronic and debilitating effects of rheumatoid arthritis (RA) — despite treatment with current therapies — achieved significant improvements in signs and symptoms when treated with Roche’s ACTEMRA (tocilizumab) alone or in combination with methotrexate compared with methotrexate alone, according to two international Phase III studies presented by researchers at the European [...]
Seven-year rheumatoid arthritis (RA) data from open-label extension studies show that treatment with Abbott’s HUMIRA (adalimumab) resulted in clinical remission among long-standing RA patients when used in combination with methotrexate (MTX). The percentage of patients achieving clinical remission continued to increase after two or more years of continuous treatment with combination therapy. These data were [...]
Travel Advantage Network (TAN), a community leader in the fight against arthritis, raised more than $2,000, placing third in Anne Arundel County’s Arthritis Walk 2008. TAN employees are active supporters of several local and national charities, focusing on a different cause each month. TAN became involved in supporting the Southern Maryland Arthritis Foundation when CEO [...]
Researchers have found that a gene region known to play a role in some varieties of adult rheumatoid arthritis is also present in all types of childhood arthritis. The researchers say the responsible gene may be a “master switch” that helps turn on the debilitating disease. Researchers at The Children’s Hospital of Philadelphia reported on [...]
Health Canada is advising consumers not to use 3rd Generation In Homoeopathy Arthrit Indica Tablet due to concerns about possible side-effects. Product label promotes use for “intense joint pain.” Arthrit Indica Tablets contain nimesulide, a pharmaceutical ingredient that is not authorized for sale in Canada. Nimesulide has been withdrawn from the market in several countries [...]
